Immediate Impact
1 from Science/Nature 52 standout
Citing Papers
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
Rheumatoid arthritis: pathogenesis and therapeutic advances
2024 Standout
Works of G. Armstrong being referenced
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
2010
Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| G. Armstrong | 157 | 27 | 45 | 353 | 142 | 24 | 671 | |
| Jeffrey B. Shiroky | 90 | 6 | 21 | 386 | 139 | 16 | 647 | |
| A M M Eijsbouts | 106 | 46 | 26 | 404 | 99 | 16 | 723 | |
| H. C. M. Haanen | 81 | 26 | 26 | 517 | 197 | 13 | 820 | |
| Y Schenk | 134 | 24 | 64 | 580 | 247 | 14 | 776 | |
| A. A. M. Blaauw | 124 | 27 | 45 | 568 | 255 | 15 | 753 | |
| Kok Yong Fong | 48 | 26 | 48 | 284 | 148 | 42 | 786 | |
| David Walker | 123 | 19 | 69 | 454 | 236 | 52 | 711 | |
| Alice Klinkhoff | 51 | 52 | 16 | 490 | 158 | 30 | 788 | |
| Amir Emamifar | 104 | 24 | 14 | 370 | 125 | 36 | 613 | |
| H.L.M. Brus | 101 | 28 | 11 | 466 | 188 | 18 | 585 |
All Works
Loading papers...